Skip to content
Open access

Synthesis and In Vitro Biological Evaluation of Amphiphilic Derivatives of Carvacrol as Potent Antibacterial Agents

Sep 2026 · Antibiotics · Vol 15 · 0 citations · 39 references
Medicine

TL;DR

The newly developed carvacrol–DABCO amphiphilic hybrids represent a promising class of multitarget antibacterial agents and their broad-spectrum efficacy, bactericidal kinetics, RNA-cleaving activity, low hemolytic toxicity, and favorable selectivity indices support their potential for further in vivo evaluation.

Abstract

Background/Objectives: The rapid emergence and spread of antibiotic-resistant bacterial strains represent a major global health threat, requiring the development of novel broad-spectrum antimicrobial agents. This study aims to design, synthesize, and evaluate a novel series of multitarget amphiphilic carvacrol derivatives to combat molecular resistance mechanisms by combining a natural monoterpene with polycationic ribonuclease scaffolds. Methods: A series of 16 dimeric carvacrol–1,4-diazabicyclo[2.2.2]octane (DABCO) hybrids, including both novel and previously reported derivatives, with varying central and lateral linkers were synthesized. In vitro antibacterial activity was evaluated against Gram-positive (S. aureus) and Gram-negative (E. coli, S. enterica, C. freundii, P. aeruginosa, A. baumannii) strains. Antibacterial action was examined through a time-kill kinetic assay against S. aureus at minimum inhibitory concentrations (MICs). RNA-hydrolyzing efficiency (using a FAM-labeled 17-mer ribooligonucleotide), hemolytic activity on rabbit red blood cells, and cytotoxicity (MTT assay) against RPMI8226, LMTK, and MEF cell lines were assessed. Results: Several compounds exhibited potent antibacterial activity, with MIC values ranging from 4 to 63 µM against most strains. The most active hybrid, DL4CAR-6, demonstrated broad-spectrum efficacy (MIC 4–16 µM against most strains) and outperformed the reference amphiphile DL4-12 against P. aeruginosa eightfold. Bacterial growth inhibition kinetic assay revealed that the cationic amphiphiles eradicate S. aureus faster than the reference antibiotic, indicating rapid membrane disruption. Most hybrids demonstrated pronounced RNA-hydrolyzing activity (up to 60% cleavage). The hemolytic assay showed less than 10% hemolysis for most compounds even at 500 µM. Furthermore, DL4CAR-6 displayed low cytotoxicity (IC50 114–250 µM), with safety thresholds exceeding effective antibacterial doses. Conclusions: The newly developed carvacrol–DABCO amphiphilic hybrids represent a promising class of multitarget antibacterial agents. Their broad-spectrum efficacy, bactericidal kinetics, RNA-cleaving activity, low hemolytic toxicity, and favorable selectivity indices support their potential for further in vivo evaluation.

Read PDF

Similar papers

Open access Oct 2026

Synthesis, antimicrobial activity and in silico studies of novel sulfonamide-benzothiazole conjugate compounds

The emergence of multidrug-resistant pathogens and polymicrobial infections underscores the urgent need for novel broad-spectrum antimicrobial agents. In this study, a series of sulfonamide–benzothiazole conjugates (4a–4j) were synthesized via a straightforward, scalable route employing thioamide formation, nucleophili...

K. Kumar, Raushan Aara · 0 citations
Sep 2026

Discovery of potent salicylanilide derivatives as effective antimicrobial agents against multidrug-resistant gram-positive pathogens.

Mechanical studies showed that D2 induced membrane depolarization and reduced intracellular ATP levels without detectable gross membrane permeabilization under the tested conditions, consistent with a membrane-associated antibacterial effect, and provide a structure-activity framework for further optimization of this c...

Pan-Pan Wang, Min Li, Yu-Hang He et al. · 0 citations
Sep 2026

Function-oriented synthesis of marine phidianidine derivatives as potent anti-MRSA agents.

Mechanistic study showed that 24a effectively inhibits biofilm formation and exerts its antibacterial effect by disrupting the bacterial cell membrane, paving the way for new strategies to combat antimicrobial resistance.

Qiong Wu, Bing-Yuan Yan, Chen Qu et al. · 0 citations
Open access Aug 2026

Total Synthesis of Paenitracin B and Analogues with Enhanced Antibacterial Activity.

The total synthesis of paenitracin B is reported, enabling definitive stereochemical validation of the previously proposed structure and delivering quantities of material suitable for more extensive antibacterial testing.

Yun-Hao Duan, Lucas Jongman, Vladyslav Lysenko et al. · 0 citations
Open access Sep 2026

In vitro evaluation of novel consensus-sequence-generated Brevinin-2 antimicrobial peptides

The consensus-sequence approach toward novel Brevinin-2 AMP discovery via alignment combined with in vitro antimicrobial analysis shows promise to test and initially validate other peptides, and establishes a streamlined pipeline for Brevinin-2 peptide development.

Colin M. McDowell, Jessica D. Carder, J. Brozik et al. · 0 citations
Open access Oct 2026

In vitro activity and comparative efficacy of novel nitrofuran-containing ciprofloxacin analogs against bacterial pathogens including ciprofloxacin-resistant Staphylococcus aureus.

The rapid rise of antimicrobial resistance, especially in Staphylococcus aureus, highlights the urgent need for improved antibacterial agents. In 2019 alone, AMR caused an estimated 1.27 million deaths and contributed to nearly 5 million more globally. Here, we present the design, synthesis, and testing of modified cip...

Kate Marshall, Patricia A. Miller, Reilly M. Coates et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.